Theresa A Bissell, MA | |
2970 Corporate Ct, Orefield, PA 18069-3158 | |
(610) 440-3534 | |
Not Available |
Full Name | Theresa A Bissell |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Addiction Medicine |
Location | 2970 Corporate Ct, Orefield, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225671662 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0300X | Preventive Medicine - Addiction Medicine | 0 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Theresa A Bissell, MA 2970 Corporate Ct, Orefield, PA 18069 Ph: () - | Theresa A Bissell, MA 2970 Corporate Ct, Orefield, PA 18069-3158 Ph: (610) 440-3534 |
News Archive
Grand jury subpoenas issued by federal investigators last week and released Tuesday by Oregon Gov. John Kitzhaber demand all records, including email correspondence related to the application or receipt of federal funds for building the state's failed website.
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.
Mobile Aspects announced today the commercial availability of an enhanced design of its RFID enabled endoscope tracking system, iRIScope. Targeted at increasing care quality and patient safety, iRIScope 2.0 offers additional functional and technical capabilities to help care providers enhance their processes for endoscope storage, use and reprocessing.
"Spending on maternal and child health has stalled, according to an expert analysis, raising concerns that efforts to cut deaths in poor countries to meet the Millennium Development Goals (MDGs) may falter," the Guardian reports.
Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."
› Verified 8 days ago